维普期刊资源整合服务平台（V6.5）

42篇 您的检索式：作者名="HILPERT F"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Bevacizumab combined with chemotherapy for platinum- resistant recurrent ovarian cancer: The AURELIA open-label randomized phase Ill trial 显示文摘	PUJADE-LAURAINE E HILPERT F WEBER B	2014	J Clin Oneol2014，32，13：	1
2	Bevacizum ab combined with chemotherapy for platinum-resistant re- current ovarian cancer: the AURELIA open-label random ized phase Ⅲ trial显示文摘	Pujane-Lauraine E Hilpert F Weber B	2014	J Clin Oncoi2014，32，13：	1
3	Clinical picture:nail changes secondary to docetaxel显示文摘	Wasner G Hilpert F Baron R	2001	Lancet2001，357，9260：	1
4	State-of-the-art first-line treatment of ovarian cancer显示文摘	Pfisterer J Hilpert F Du Bois A	2003	Onkologie2003，26，5：	1
5	Studien zur Systematik der Trichostomaceen显示文摘	HILPERT F		0，，02：	1
6	Systemic therapy in recurrent ovarian cancer: current treatment options and new drugs 显示文摘	Hatter P Hilpert F Mahner S	2010	Expert Rev Anticancer Ther2010，10，1：	1
7	Studien zur Systematik der Trichostomaceen显示文摘	Hilpert F	1933	Beih Bot Centralbl1933，50，2：	1
8	Diagnosis and manage-ment of an unilateral giant fibroadenoma of the breast in pregnan cy显示文摘	Heilmann T Leuschner I Hilpert F	2012	Arch Gynecol Obstet2012，285，1：	1
9	Doeetaxel-indueed nail changesea neurogenic mechanism : a case report 显示文摘	Wasner G Hilpert F Sehattschneider J	2002	Journal of Neu- rooncology2002，58，2：	1
10	AURELIA:a randomized phase M trial evaluating bevacizumab(BEV)plus chemotherapy(CT)for platinum(PT)-resistant recurrent ovarian cancer(OC)显示文摘	Pujade-Lauraine E Hilpert F Weber B	2012	J Clin Oncol(Meeting Abstracts)2012，30，18：	1
11	Comprehensive analysis of NKG2D ligand expression and release in leukemia: implication for NKG2D-mediated NK cell responses 显示文摘	Hilpert J Grosse-Hovest L Grtinebach F	2012	J Immunol2012，189，3：	1
12	Feasibility,toxicity and quality of life of first-line chemotherapy with platinum/paclitaxel in elderly patients aged or=70 years with advanced ovarian cancer-a studyby the AGOOVAR Germany显示文摘	du Bois A Greimei ER	2007	Ann Oncol2007，18，2：	1
13	Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial显示文摘	Pujade-Lauraine E Hilpert F Weber B	2014	J CLIN ONCOL2014，32，13：	1
14	AURELIA: A randomized phase III trial evaluating bevacizumab (BEV) plus chemotherapy (CT) for platinum (PT) -- resistant recurrent ovarian cancer(OC) (LBAS002) 显示文摘	Pujade-- Lauraine E Hilpert F Weber B	2012	J Clin Oneol2012，30，18：	1
15	Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer:the AURELIA open-label randomized phaseⅢtrial显示文摘	Pujade-Lauraine E Hilpert F Weber B	2014	J Clin Oncol2014，32，13：	1
16	Early loss of pericytes and perivascular stromal cell-induced scar for- mation after stroke 显示文摘	Femandez-Klett F Potas JR Hilpert D	2013	J Cereb Blood Flow Metab2013，33，：	1
17	Comprehensive analysis of NKG2D Iigand expression and release in leukemia:implications for NKG2Dmediated NK cell responses显示文摘	Hilpert J Grosse-Hovest L Grtinebach F		0，，03：	1
18	Comprehensive analysis of NKG2D ligand expression and release in leukemia: Implications for NKG2D-mediated NK cell responses 显示文摘	Hilpert J Grosse-Hovest L Griinebach F	2012	J Immunol2012，189，3：	1
19	Feasibility, toxicity and quality of life of first-line chemotherapy with platinum/paclitaxel in elderly patients aged > or = 70 years with advanced ovarian cancer-a study by the AGOOVAR Germany 显示文摘	Hilpert F du Bois A Greimel ER	2007	Ann Oncol2007，18，2：	1
20	AURELIA: a ran domized phase Ⅲ trial evaluating bevacizumab (BEV) plus chemo- therapy (CT) for platinum (PT) resistant recurrent ovarian canc- er (OC) 显示文摘	Pujade-Lauraine E Hilpert F Weber B	2012	J Clin Oncol2012，30，18：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示